122 | IDENTIFYING HARMFUL HYPERINFLAMMATION IN DIFFUSE LARGE B‐CELL LYMPHOMA USING THE OHI (OPTIMIZED HLH INFLAMMATORY) INDEX—DISCOVERY AND VALIDATION IN REAL‐WORLD PATIENTS
Hematological Oncology · 2025-06 · 43 (S3)
DOI: 10.1002/hon.70093_122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematological Oncology, online erschienen am 16.06.2025. Verfasst von A. Zoref‐Lorenz und 17 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zoref‐Lorenz, A., Cahn, E. J., Mou, E., Cholack, G., Wang, Y., Maurer, M., Feldman, A. L., Negaard, B. J., Mwangi, R., Itchaki, G., Nowakowski, G., Habermann, T. M., Link, B. K., Ansell, S. M., Novak, A. J., Witzig, T. E., Cerhan, J. R., & Jordan, M. (2025). 122 | IDENTIFYING HARMFUL HYPERINFLAMMATION IN DIFFUSE LARGE B‐CELL LYMPHOMA USING THE OHI (OPTIMIZED HLH INFLAMMATORY) INDEX—DISCOVERY AND VALIDATION IN REAL‐WORLD PATIENTS. Hematological Oncology, 43(S3). https://doi.org/10.1002/hon.70093_122
Vancouver
Zoref‐Lorenz A, Cahn EJ, Mou E, Cholack G, Wang Y, Maurer M, et al. 122 | IDENTIFYING HARMFUL HYPERINFLAMMATION IN DIFFUSE LARGE B‐CELL LYMPHOMA USING THE OHI (OPTIMIZED HLH INFLAMMATORY) INDEX—DISCOVERY AND VALIDATION IN REAL‐WORLD PATIENTS. Hematological Oncology. 2025;43(S3). doi:10.1002/hon.70093_122
BibTeX
@article{ZorefLorenz2025,
author = {Zoref‐Lorenz, A. and Cahn, E. J. and Mou, E. and Cholack, G. and Wang, Y. and Maurer, M. and Feldman, A. L. and Negaard, B. J. and Mwangi, R. and Itchaki, G. and Nowakowski, G. and Habermann, T. M. and Link, B. K. and Ansell, S. M. and Novak, A. J. and Witzig, T. E. and Cerhan, J. R. and Jordan, M.},
title = {122 | IDENTIFYING HARMFUL HYPERINFLAMMATION IN DIFFUSE LARGE B‐CELL LYMPHOMA USING THE OHI (OPTIMIZED HLH INFLAMMATORY) INDEX—DISCOVERY AND VALIDATION IN REAL‐WORLD PATIENTS},
journal = {Hematological Oncology},
year = {2025},
volume = {43},
number = {S3},
doi = {10.1002/hon.70093_122}
}
EUVIMED